3 Ways to Maximize Your $7,000 TFSA Contribution for Long-Term Growth

Investing in these Canadian stocks can help diversify your TFSA portfolio, add stability, and generate significant capital gains.

| More on:
The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.

Source: Getty Images

A Tax-Free Savings Account (TFSA) is an attractive investment channel. Offering tax-free gains on savings, a TFSA can be leveraged for financial planning. For 2025, the annual contribution limit has been set at $7,000. How you choose to invest that amount can significantly impact your financial future.

One of the ways to maximize your contribution for long-term growth is to hold different assets – such as stocks, mutual funds, ETFs, and bonds – in your portfolio. Diversification helps spread risk. Secondly, make consistent annual contributions and allow your investments to compound over the years. Notably, without the drag of taxes, you can amplify your gains.

While a balanced portfolio is essential, investors seeking strong long-term growth should consider allocating a greater proportion to equities, as they tend to generate higher returns over the long term.

With these three principles in mind, let’s look at three Canadian stocks that could help you make the most of your $7,000 TFSA contribution this year.

Dollarama stock

Dollarama (TSX:DOL) is a compelling long-term investment for those seeking stability and growth in their TFSA portfolio. This Canadian dollar-store chain has outpaced the broader market, driven by a resilient business model that performs well in all economic conditions. By offering everyday essentials at consistently low prices, Dollarama ensures strong customer loyalty, which drives steady financial performance. Its expanding store network further strengthens its reach and boosts sales.

Year to date, Dollarama stock has gained 25.2%, and over the past five years, it has delivered an impressive 279.5% return. The company also rewards investors with growing dividends, having raised its payout 14 times since 2011.

Looking ahead, Dollarama’s broad product range, value-focused pricing, and cost-efficient operations are poised to drive further gains.

Celestica stock

TFSA investors seeking long-term growth could consider Celestica (TSX:CLS). While shares of this Canadian tech company have gained significantly, the stock still holds strong upside potential, thanks to its presence in the rapidly expanding artificial intelligence (AI) market.

Celestica’s Connectivity & Cloud Solutions (CCS) division is experiencing significant growth, driven by surging demand from hyperscalers for networking hardware. In Q1, revenue from its Hardware Platform Solutions (HPS) unit nearly doubled to over $1 billion and accounted for 39% of total sales, reflecting AI-driven demand for 400G and 800G switches.

At the same time, Celestica’s Advanced Technology Solutions (ATS) business will also deliver solid growth led by steady demand for capital equipment and early signs of an industrial rebound. Thanks to its strong growth prospects, Celestica is poised to deliver substantial returns in the coming years.

Hydro One stock

Hydro One (TSX:H) is another attractive pick for TFSA investors to generate solid capital gains and dividend income in the long term. The Canadian utility company engages in electricity transmission and distribution without exposure to volatile commodity prices. Further, its regulated business model ensures predictable earnings and reliable cash flow, making it a low-risk, defensive investment.

Despite its conservative operations, Hydro One has delivered strong returns. Its stock has appreciated by more than 117% in the past five years. Moreover, Hydro One has consistently increased its dividend, enhancing its shareholder value.

With growing electricity demand and its expanding rate base, Hydro One is well-positioned to offer both income and long-term growth. Moreover, its resilient business model will add stability to your TFSA portfolio.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Retirement

Canadian Red maple leaves seamless wallpaper pattern
Dividend Stocks

CRA Just Released New 2026 Tax Brackets

New 2026 CRA tax brackets can cut “bracket creep” so plan around them to ensure more compounding, and consider Manulife…

Read more »

monthly calendar with clock
Dividend Stocks

How to Use Your TFSA to Earn $700 per Month in Tax-Free Income

Turn your TFSA into a steady, tax‑free monthly paycheque, Here’s a simple plan and why APR.UN fits the bill.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How I’d Structure a $50,000 TFSA for Almost Constant Income

Turn a $50,000 TFSA into a dependable, tax‑free paycheque with a simple ETF mix. Here’s why VDY can anchor the…

Read more »

shopper pushes cart through grocery store
Dividend Stocks

The Canadian Dividend Stock I’d Trust for the Next Decade

This northern grocer could anchor a 10‑year dividend plan. Here’s why NWC’s essential markets and steady cash flows make it…

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Dividend Stocks

Here’s the Average TFSA Balance at Age 55 in Canada

Turning 55? See how a TFSA and a low‑volatility income ETF like ZPAY can boost tax‑free retirement cash flow while…

Read more »

View of high rise corporate buildings in the financial district of Toronto, Canada
Dividend Stocks

How to Use Your TFSA to Earn $275 in Monthly Tax-Free Income

Discover how True North Commercial REIT’s government‑anchored leases could help turn a TFSA into monthly, tax‑free income even amid a…

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

Top TSX Dividend Stocks for Retirees

Picking dividend stocks for retirees involves a different set of criteria compared to non-retirees. Here are some great picks to…

Read more »

doctor uses telehealth
Dividend Stocks

1 Magnificent Canadian Dividend Down 62% to Buy and Hold for Decades

This overlooked healthcare REIT may be turning the corner. Here’s why its beaten‑down price could reward patient, income‑focused investors.

Read more »